Promethera Therapeutics is pioneering the development of cutting-edge cell-based therapies for the treatment of liver to reduce the need for transplantation.
View all
Celyad
Mont-Saint-Guibert, Belgium · Post IPO Equity
Applied StemCell
Milpitas, United States · Series D
AnaptysBio
San Diego, United States · IPO
Kallyope
New York, United States · Grant
Mammoth Biosciences
Brisbane, United States · Series D
Biofourmis
Boston, United States · Series D
Ecovative Design
Green Island, United States · Series D
ViaCyte
San Diego, United States · Series D
Akoya Biosciences
San Francisco, United States · Series D
Century Therapeutics
Philadelphia, United States · Post IPO Equity
Maze Therapeutics
South San Francisco, United States · Venture
Passage Bio
Philadelphia, United States · Post IPO Equity